Martin Eden
About
Martin Eden is a scholar working on General Health Professions, Geriatrics and Gerontology and Economics and Econometrics.
According to data from OpenAlex, Martin Eden has authored 35 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in General Health Professions, 9 papers in Geriatrics and Gerontology and 8 papers in Economics and Econometrics. Recurrent topics in Martin Eden's work include Pharmaceutical Practices and Patient Outcomes (9 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Genomics and Rare Diseases (4 papers). Martin Eden is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (9 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Genomics and Rare Diseases (4 papers). Martin Eden collaborates with scholars based in United Kingdom, United States and Australia. Martin Eden's co-authors include Karen Hassell, Ellen Schafheutle, Anthony Avery, Rachel Elliott, Matthew Franklin, Koen Putman, Aziz Sheikh, Sarah Rodgers, R.J. Prescott and Katherine Payne and has published in prestigious journals such as The Lancet, BMJ and British Journal of Dermatology.
In The Last Decade
Martin Eden
33 papers receiving 877 citations
Peers
Martin Eden
Mark Makowsky Canada
Lisa M. Guirguis Canada
Terry Porteous United Kingdom
Virginia Wang United States
Anna Kemp Australia
Junya Zhu United States
John D. Voss United States
Eric J. MacLaughlin United States
Nesé Yuksel Canada
Lindsey Yourman United States
Citations per year, relative to Martin Eden Martin Eden (= 1×)
peers
Mark Makowsky
Countries citing papers authored by Martin Eden
Since
Specialization
Citations
This map shows the geographic impact of Martin Eden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Eden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Eden more than expected).
Fields of papers citing papers by Martin Eden
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Martin Eden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Eden. The network helps show where Martin Eden may publish in the future.
Co-authorship network of co-authors of Martin Eden
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Eden. A scholar is included among the top collaborators of Martin Eden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Eden. Martin Eden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Eden, Martin, Jonathan Ghosh, Vivak Hansrani, et al.. (2024). Detection and Coil Embolisation of Pelvic Vein Incompetence for Chronic Pain in the Female Pelvis: A Development Phase Economic Analysis. European Journal of Vascular and Endovascular Surgery. 69(3). 474–482.
2.
Whittaker, William, James Higgerson, Martin Eden, et al.. (2024). Effects of employees living with an ‘arthritis’ on sickness absence and transitions out of employment: a comparative observational study in the UK. RMD Open. 10(4). e004817–e004817.
3.
Eden, Martin, Louisa G. Gordon, Tracy Epton, et al.. (2022). Cost‐effectiveness of a policy‐based intervention to reduce melanoma and other skin cancers associated with indoor tanning*. British Journal of Dermatology. 187(1). 105–114.
4.
Chatzimavridou-Grigoriadou, Victoria, Lisa Barraclough, Robert G. Bristow, et al.. (2022). RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy. BMJ Open. 12(6). e056600–e056600.
5.
Gordon, Louisa G., Martin Eden, Tracy Epton, et al.. (2021). Sunbed Use among 11- to 17-Year-Olds and Estimated Number of Commercial Sunbeds in England with Implications for a ‘Buy-Back’ Scheme. Children. 8(5). 393–393.
6.
White, Katherine, Caroline Henson, Mark Hann, et al.. (2020). Randomised clinical trial of a gastrointestinal care bundle to reduce symptoms in patients with pelvic cancer undergoing chemoradiotherapy. BMJ Open Gastroenterology. 7(1). e000432–e000432.
7.
Hammond, Alison, Chris Sutton, Sarah Cotterill, et al.. (2020). The effect on work presenteeism of job retention vocational rehabilitation compared to a written self-help work advice pack for employed people with inflammatory arthritis: protocol for a multi-centre randomised controlled trial (the WORKWELL trial). BMC Musculoskeletal Disorders. 21(1). 607–607.
8.
Payne, Katherine & Martin Eden. (2018). Measuring the economic value of genetic counselling. European Journal of Medical Genetics. 62(5). 385–389.
9.
Payne, Katherine, Martin Eden, Marion McAllister, et al.. (2017). Exploring the feasibility of delivering standardized genomic care using ophthalmology as an example. Genetics in Medicine. 19(9). 1032–1039.
10.
Wright, Stuart, Debbie Gibson, Martin Eden, et al.. (2017). What are colorectal cancer survivors’ preferences for dietary advice? A best-worst discrete choice experiment. Journal of Cancer Survivorship. 11(6). 782–790.
11.
Eden, Martin, Katherine Payne, Stuart Wright, et al.. (2016). Identifying variation in models of care for the genomic-based diagnosis of inherited retinal dystrophies in the United Kingdom. Eye. 30(7). 966–971.
12.
Harrison, Mark, Stephen Birch, Martin Eden, et al.. (2015). Variation in healthcare services for specialist genetic testing and implications for planning genetic services: the example of inherited retinal dystrophy in the English NHS. Journal of Community Genetics. 6(2). 157–165.
13.
Elliott, Rachel, Koen Putman, Matthew Franklin, et al.. (2014). Cost Effectiveness of a Pharmacist-Led Information Technology Intervention for Reducing Rates of Clinically Important Errors in Medicines Management in General Practices (PINCER). PharmacoEconomics. 32(6). 573–590.
14.
Elliott, Rachel, Koen Putman, Matthew Franklin, et al.. (2013). Determining Economic Impact Of A Pharmacist-Led It-Based Intervention With Simple Feedback In Reducing Rates Of Clinically Important Errors In Medicines Management In General Practices (PINCER). Value in Health. 16(3). A206–A206.
15.
Eden, Martin, Katherine Payne, Ryan Combs, et al.. (2013). Valuing the benefits of genetic testing for retinitis pigmentosa: a pilot application of the contingent valuation method. British Journal of Ophthalmology. 97(8). 1051–1056.
16.
Kennedy, Anne, Peter Bower, David Reeves, et al.. (2013). Implementation of self management support for long term conditions in routine primary care settings: cluster randomised controlled trial. BMJ. 346(may13 3). f2882–f2882.
17.
Bower, Peter, Anne Kennedy, David Reeves, et al.. (2012). A cluster randomised controlled trial of the clinical and cost-effectiveness of a 'whole systems' model of self-management support for the management of long- term conditions in primary care: trial protocol. Implementation Science. 7(1). 7–7.
18.
Hassell, Karen, et al.. (2011). Workload in community pharmacies in the UK and its impact on patient safety and pharmacists’ well-being: a review of the evidence. Health & Social Care in the Community. 19(6). 561–575.
19.
Eden, Martin, Ellen Schafheutle, Sarah Willis, Seston Em, & Karen Hassell. (2008). Why some pharmacists choose non-standard careers soon after qualifying?. International Journal of Pharmacy Practice.
20.
Hassell, Karen & Martin Eden. (2006). Workforce update - joiners, leavers, and practising and non-practising pharmacists on the 2005 Register. Pharmaceutical journal/The pharmaceutical journal. 276(7383). 383–385.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Mark Makowsky Breakdown of academic impact, for papers by Lisa M. Guirguis Breakdown of academic impact, for papers by Terry Porteous Breakdown of academic impact, for papers by Virginia Wang Breakdown of academic impact, for papers by Anna Kemp Breakdown of academic impact, for papers by Junya Zhu Breakdown of academic impact, for papers by John D. Voss Breakdown of academic impact, for papers by Eric J. MacLaughlin Breakdown of academic impact, for papers by Nesé Yuksel Breakdown of academic impact, for papers by Lindsey Yourman